Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome.

Johnson, B.,Giri, S.,Nunnery, S. E.,Wiedower, E.,Jamy, O.,Yaghmour, G.,Chandler, J. C.,Martin, M. G.; Clin Lymphoma Myeloma Leuk. 2016 Feb 04.

Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic target.

Park, I. K.,Mishra, A.,Chandler, J.,Whitman, S. P.,Marcucci, G.,Caligiuri, M. A.; Blood. 2013 Mar 14.